-We previously reported that excess of deoxycorticosterone-acetate (DOCA)/salt-induced cardiac hypertrophy in the absence of hypertension in one-renin gene mice. This model allows us to study molecular mechanisms of high-salt intake in the development of cardiovascular remodeling, independently of blood pressure in a high mineralocorticoid state. In this study, we compared the effect of 5-wk low-and high-salt intake on cardiovascular remodeling and cardiac differential gene expression in mice receiving the same amount of DOCA. Differential gene and protein expression was measured by high-density cDNA microarray assays, real-time PCR and Western blot analysis in DOCA-high salt (HS) vs. DOCA-low salt (LS) mice. DOCA-HS mice developed cardiac hypertrophy, coronary perivascular fibrosis, and left ventricular dysfunction. Differential gene and protein expression demonstrated that high-salt intake upregulated a subset of genes encoding for proteins involved in inflammation and extracellular matrix remodeling (e.g., Col3a1, Col1a2, Hmox1, and Lcn2). A major subset of downregulated genes encoded for transcription factors, including myeloid differentiation primary response (MyD) genes. Our data provide some evidence that vascular remodeling, fibrosis, and inflammation are important consequences of a high-salt intake in DOCA mice. Our study suggests that among the different pathogenic factors of cardiac and vascular remodeling, such as hypertension and mineralocorticoid excess and sodium intake, the latter is critical for the development of the profibrotic and proinflammatory phenotype observed in the heart of normotensive DOCA-treated mice.
definitively one of the major triggers for the development of cardiac hypertrophy in hypertension, several nonhemodynamic factors can contribute to the pathophysiology of LVH, such as sex, age, race, obesity, alcohol consumption, catecholamines, aldosterone, and ANG II (2, 8, 12) .
It is well established that an excessive sodium chloride (salt) intake can exacerbate hypertension and hence further increase left ventricular mass (10) . However, there is also some evidence that suggests a high-salt intake induces cardiac hypertrophy independently of its effect on blood pressure (13, 29) . The impact of salt on the left ventricle is particularly important in animals exposed to an excess of mineralocorticoids as in the deoxycorticosterone-salt (DOCA-salt) hypertension rat model (3, 37, 38) . Although the DOCA-salt model is hypertensive, several pieces of evidence also suggest that aldosterone can directly damage target organs, such as the heart and the kidney, independently of any change in blood pressure (3, 4, 12, 24) . These data are strengthened by one of our previous studies, demonstrating that in one-renin gene mice, DOCA-salt induces cardiac and renal hypertrophy in the absence of hypertension (36) . Moreover, there is some evidence showing that aldosterone-induced organ damages develop essentially when animals receive a sufficient amount of salt in their diet (3, 27, 37, 38) . In support of this hypothesis, cardiac fibrosis does not develop in mice with a salt-losing nephropathy despite 5-or 6-fold chronic increases in plasma aldosterone levels (15) . Similarly, cardiac-specific increases in aldosterone cause no cardiac hypertrophy and fibrosis in rodents fed with a low-or a normalsalt diet (33, 37) . These data, therefore, suggest that salt is a required cofactor for the development of mineralocorticoidinduced organ damages.
The molecular mechanisms, whereby salt favors the development of cardiac hypertrophy in situations of hyperaldosteronism are poorly understood. In this study, we used cDNA microarray technology to study the effect of high-salt intake on cardiovascular remodeling and cardiac differential gene expression in mice with stable mineralocorticoid excess. To this purpose, we used our recently developed one-renin gene DOCA/ salt mouse model, in which cardiac hypertrophy develops in the absence of hypertension (36) .
MATERIALS AND METHODS
Animals. Experiments were performed on 7-wk-old, male, wildtype backcross N [5] [6] (129 Ola/C57BL/6J) one-renin gene mice derived from the Institute of Pharmacology, University of Lausanne, Switzerland, that were homozygous for the Ren-1 c gene locus (36) . The experiments were approved by an institutional committee for the humane use of animals. All mice were housed in a temperature-and humidity-controlled room with an automatic 12:12-h light-dark cycle. In this set of experiments, all mice were uninephrectomized, and silicone tubing filled with 35 mg of DOCA powder (Sigma) with a consistent release rate of DOCA was implanted subcutaneously, as described earlier (36) . Mice were then fed either with low-sodium (LS) pellet containing 0.5 mg of sodium/g and 6 mg of potassium/g (UAR 212 Na; Usine d'Alimentation Rationnelle, Epinay-sur-Orge, France) and tap water as drinking fluid (DOCA-LS group) or normal sodium pellet containing 3 mg of sodium/g and ϳ6 mg of potassium/g (UAR-AO3; Usine d'Alimentation Rationnelle) and 1% NaCl as drinking fluid [DOCA-high salt (HS)]. After 5 wk, blood pressure, heart rate, and left ventricular hemodynamic parameters were measured in the conscious mice as published before (32) . Overall, mineralocorticoid activity was assessed by measuring the amiloridesensitive rectal potential difference (⌬PD amil) in the distal colon, as described previously (35) .
Biochemical measurements. Blood was taken at the end of the experiments for the determination of serum and potassium. These parameters were measured by flame photometry (Instrumentation Laboratory 943). Blood pH was measured by a pH/blood gas analyzer (Gas Analyzer 248; Bayer Schweiz AG).
Cardiac histology and image analysis. At the end of the experiments, hearts were excised and washed with cold PBS, weighted, either frozen with liquid nitrogen, and stored at Ϫ80°C for molecular examinations or fixed with formalin (3.8%) overnight for the histology. Cardiac hypertrophy was determined by heart weight-to-body weight ratio, i.e., cardiac weight index (mg/g). For histological analysis, 4-m sections were cut through the middle horizontal plane of formaldehyde-fixed, paraffin-embedded hearts and stained with Elastica van Gieson stain, according to standard protocols. Three representative ϫ20 fields, each containing single arterioles, were photographed using a digital camera and imported into Photoshop (version 7.0; Adobe Systems). Using the "magic wand" tool and the "select similar" command, we selected all red-stained perivascular fibrotic tissue and the surface quantified by the "histogram" tool (given in pixel per inch). Vessel circumference was assessed similarly. The extent of perivascular fibrosis was calculated and given as perivascular fibrosis thickness relative to normalized vessel circumference.
Cardiac RNA extraction, real-time PCR, and cDNA microarray assays. Expression of mRNAs of interest was assessed by cDNA microarray assays and real-time PCR of extracted ventricles from DOCA-HS and DOCA-LS mice. Total RNA was purified from heart tissue by TRIzol reagent (Invitrogen), according to manufacturer's protocol. Resulting cDNAs were subjected to quantitative real-time PCR using the TaqMan 7500 Fast Real-Time PCR System apparatus (Applied Biosystems) and TaqMan Chemistry that uses fluorogenic probes (TaqMan MGB probes, FAM dye-labeled). Data reported in the RESULTS were calculated as a gene of interest-to-GAPDH ratio (in arbitrary units). Results are expressed as a fold increase of the gene of interest in DOCA-HS compared with DOCA-LS hearts. cDNA microarray slides were produced at the DNA Array Facility (DAF) in Lausanne, Switzerland by 32-pin robotic printing. The specific clone set printed onto the slides was the NIA 15K mouse embryonic clone set (National Institute of Aging, NIH, Bethesda, MD), to which an additional 1563 custom clone set was added. Statistically normalized clones were ranked in order of magnitude of differential expression (i.e., normalized M values), for positive and negative values. The GEO repository database reports the raw data for each hybridization performed (http://www.ncbi.nlm.nih.gov/geo/; series GSE5946).
Gene ontology classification of selected transcript candidates. cDNA microarray clones that presented significant patterns of differential expression (1.5-fold upregulation or downregulation and P Ͻ 0.05) were clustered according to the Gene Ontology (GO) Consortium classification groups (http://www.geneontology.org/index.shtml). The list of differentially expressed genes was examined for overrepresentation of GO annotation classes using the EASE tool (1, 14) .
Protein extraction and Western blotting. Protein expression was measured by performing Western blot analysis on heart extracts. Data are expressed as means Ϯ SE. HR, heart rate; MBP, intra-arterial mean blood pressure; LVEDP: left ventricular end diastolic pressure; CWI, cardiac weight index; rectal ami-S-PD, rectal amiloride-sensitive potential difference. **P Ͻ 0.01, ***P Ͻ 0.001, DOCA-HS vs. DOCA-LS. Cardiac tissue was homogenized in a hypotonic buffer (NXTRACT; Sigma) supplemented with a cocktail of protease and phosphatase inhibitors, according to recommended brand protocols (cOmplete, and PhosSTOP, Roche). Nuclear protein extracts were separated from the homogenates using the NXTRACT CelLytic NuCLEAR Extraction Kit (Sigma). Immunodetection of protein expression was performed according to standard Western blotting protocols on nitrocellulose membrane. Values were expressed (in arbitrary units) as protein levels detected and normalized to the housekeeping protein GAPDH.
Statistics. All physiological parameters are presented as means Ϯ SE. Statistical comparisons between groups were performed by a one-way ANOVA, followed by a Newman-Keuls test. P Ͻ 0.05 was considered the minimal level of significance.
RESULTS

Systemic and cardiac hemodynamics.
Overall, mineralocorticoid activity as determined by the amiloride-sensitive rectal PD was comparable in DOCA-LS (Ϫ40 Ϯ 1 mV) and DOCA-HS (Ϫ43 Ϯ 3 mV) groups (Table 1 ). The amiloridesensitive rectal PDs in LS, HS, and normal-salt-fed mice without DOCA implant were Ϫ26 Ϯ 2.0 mV, Ϫ3 Ϯ 0.3 mV (data not shown in Table. 1), and Ϫ11 Ϯ 2 mV (36), respectively. Blood pressure, heart rate, and body weight were also comparable in the two groups (Table. 1 ). The only significant difference concerned serum potassium, which was lower in the DOCA-HS group; and plasma pH, which was higher in the DOCA-HS group, reflecting a greater metabolic alkalosis in the DOCA-HS group of mice. Cardiac hypertrophy was present in the DOCA-HS group and absent in the DOCA-LS group (P Ͻ 0.01, Table 1 ). As previously published, in uninephrectomized mice on a regular salt intake, cardiac weight index was 4.1 Ϯ 0.1 mg/g, which is not statistically different than DOCA-LS group, suggesting that cardiac remodeling correlated with high-salt intake (34, 36) . Left ventricular systolic pressure was also comparable in DOCA-HS vs. DOCA-LS groups of mice (Fig. 1A) . However, the absolute values of LVdP/dt max and LVdP/dt min were significantly decreased, the time constant of isovolumic relaxation (Weiss Tau, ) was significantly prolonged, and the left ventricular end diastolic pressure was significantly increased in DOCA-HS group compared with the DOCA-LS, suggesting left ventricular dysfunction (Fig. 1 , B and C, and Table. 
1).
Coronary perivascular fibrosis in DOCA-HS heart. Fig. 2 qualitatively shows that coronary arterial perivascular fibrosis and vessel wall thickness were greater in DOCA-HS than in DOCA-LS mice. When quantified, perivascular fibrosis was significantly higher in DOCA-HS mice than in DOCA-LS mice (32 Ϯ 3.1 vs. 14 Ϯ 1.6, P Ͻ 0.05, n ϭ 5 mice per group, 2 or 3 vessels per mouse, measuring perivascular fibrosis thickness relative to normalized vessel circumference).
Expression of cardiac markers in DOCA-HS mice. Several markers of cardiac hypertrophy and heart failure were analyzed by real-time PCR in ventricular tissues extracted from DOCA-HS and DOCA-LS mice. The results showed that skeletal actin (Acta1) was ϳ3.8 times upregulated in ventricles after 5 wk of high-salt treatment in DOCA mice. The same treatment did not change the expression of other known markers of cardiac and cardiomyocyte remodeling, including the cardiac actin isoform Actc1, the alpha-and beta-myosin heavy-chain isoforms Myh6 and Myh7, the BNP natriuretic factor (Nppb), the troponin I isoform Tnni3, and the Gata4 and Nkx2.5 transcription factors (Fig. 3) .
Salt-induced cardiac differential genes expression. cDNA high-density microarray assays were used to explore changes (Table 2 and 3) . Of these 106 transcripts, 76 (ϳ72%) were (Ͼ1.5-fold) upregulated and 30 (ϳ28%) were (Ͼ1.5-fold) downregulated. The list of differentially expressed genes was examined for overrepresentation of GO annotation classes using the EASE tool (1, 14) . Of note, the "cellular process," "extracellular," "extracellular matrix," and "collagen" GO categories scored a statistically significant EASE score (P Ͻ 0.01) among the upregulated transcripts, indicating overexpression of extracellular matrix and collagenrelated genes in DOCA-HS hearts ( Table 2) . The "DNA binding," "regulation of transcription," "transcription regulatory activity," and "transcription factor activity" GO categories were significantly overrepresented among the downregulated transcripts (EASE score, P Ͻ 0.01), suggesting downregulation of genes coding for transcription factors in DOCA-HS hearts when profiling by cDNA microarray assays was reliable, four candidate genes (two upregulated and two downregulated) were confirmed by real-time PCR. Our data showed that Col3a1 and Serpinf1 were significantly upregulated, while Egr1 and Irf2 transcription factors were significantly downregulated in DOCA-HS mice by both cDNA microarray and real-time PCR approaches (Tables 2 and 3 and Fig. 3 ). The magnitude of differential gene expression measured by cDNA microarray assays and real-time PCR was equivalent.
Protein expression and NF-B signaling pathway. To confirm that gene expression profiling was also associated with differential expression at the translational level, we performed Western blot analysis on selected protein candidates. The results showed a ϳ3-to 4-fold upregulation of collagen isoforms III and I and a ϳ5-fold upregulation of lipocalin (Lcn) in DOCA-HS mice. We also demonstrated a ϳ3-fold downregulation of the transcription factor Egr1. Our data showed that collagen isoforms and lipocalin were significantly upregulated, while the Egr1 transcription factor was significantly downregulated in DOCA-HS mice both at the mRNA and protein levels (Fig. 5) . Because Egr1 is a major regulator of NF-B signaling pathway (see DISCUSSION) , we measured the expression of NF-B subunits p65 and p50 in DOCA-HS vs. DOCA-LS hearts. Results showed no variability in total protein expression for these subunits, but a strong downregulation of the Ser-276 phosphorylated form of p65 in nuclear extracts from DOCA-HS hearts was observed (Fig. 4) . These data suggest that downregulation of Egr1 is associated with inactivation of NF-B in DOCA-HS mice.
DISCUSSION
The results of the present study largely confirm that salt is a determinant cofactor leading to the development of cardiac hypertrophy and fibrosis in states of mineralocorticoid excess (12, 15) . Indeed, on a low-salt diet, mice receiving an excess of DOCA do not develop cardiac hypertrophy, fibrosis, and cardiac dysfunction. Yet, DOCA-treated mice present signs of mineralocorticoid excess, as shown by a higher amiloridesensitive rectal PD and the development of hypokalemia and metabolic alkalosis (Table 1) .
Cardiac hypertrophy and left ventricular dysfunction develop in DOCA mice receiving a high-salt diet, even though blood pressure remains normal and comparable to mice on a low-salt diet. This observation is of primary importance as it eliminates the confounding factor of pressure overload, the most important clinical trigger of LVH (10) . Interestingly, the only significant differences observed between DOCA-HS and the DOCA-LS mice concern the severity of the metabolic alkalosis and hypokalemia, which was more pronounced on a high-salt diet. The changes in serum potassium could actually contribute to the differences observed in cardiac gene expres- Clones are ranked according to their "fold increase" value, in descending order (i.e., the most upregulated clones in DOCA-high-salt hearts being on top of the list). The first column reports the clone ID according to the NIA17K annotation; the TaqMan column shows the gene candidates that were confirmed by real-time PCR; the last four columns report the gene ontology categories which were significantly overrepresented among the upregulated transcripts. CP, cellular process (biological process); E, extracellular (cellular component); EM, extracellular matrix (cellular component); C, collagen (cellular component). The transcripts belonging to one or more of these categories are marked with an "X".
sion, as we have recently demonstrated that the correction of hypokalemia can prevent the development of cardiac hypertrophy in this mouse model (34) . Therefore, the impact of changes in serum potassium on cardiac physiology and gene expression would, therefore, deserve some particular attention in future studies.
Nevertheless, there are several indications that salt loading plays a direct role on the development of fibrosis and vascular hypertrophy. Some literature demonstrated that increasing the concentration of sodium in the medium by as little as 6 mmol/l above a normal control value of 146 mmol/l for 5 days caused substantial hypertrophy of both myocardial myoblasts and vascular smooth muscle cells (13) . In addition, dietary high salt led to widespread fibrosis in the heart and kidney in WistarKyoto and spontaneously hypertensive rats (39) or in the kidney of aldosterone-perfused rats (21) .
To confirm that cardiac remodeling and left ventricular dysfunction in DOCA-HS mice compared with the DOCA-LS were associated with changes in cardiomyocyte-specific gene expression, several genetic markers for cardiomyocyte hypertrophy were analyzed by real-time PCR (Fig. 3) . The present data showed that cardiac hypertrophy and left ventricular dysfunction are associated with differential gene expression of fetal actin but not myosin isogenes. Data also suggest that chronic mechanisms of cardiac and cardiomyocyte hypertrophy in DOCA mice on a high-salt diet are neither dependent on the Gata4-and Nkx-2.5-dependent transcription pathways, nor on troponin I (Tnni3) or BNP natriuretic factor (Nppb), which are commonly activated during cardiogenesis and agonist-or stretch-induced hypertrophy (16, 22, 23, 26) . However, one has to mention that gene expression was measured after 5 wk of DOCA and high-salt diet. Thus, one cannot exclude that such pathways were either transiently modulated in early/acute stages of the same diet or, possibly, activated at later chronic stages.
Our histological data showed that perivascular fibrosis is a major component of cardiac remodeling in DOCA-HS mice. Our cDNA microarray data confirm this morphological observation and suggest that high-salt intake is critical for the development of the profibrotic and proinflammatory phenotype associated with an excess of mineralocorticoids. An enriched subset of genes found to be differentially upregulated between high-salt and low-salt treatment coded for extracellular matrix (ECM) proteins, including basement membrane constituents (Sparc), collagen isoforms (Col3a1, Col1a2, Col4a1, Col5a1, Col6a1), proteases (Mmp2), proteoglycans (Lum), protease inhibitors (Timp3), and other genes playing a role in ECM structure, adhesion, binding, and collagen maturation (Mfap4, Tnc, Fstl3, Pcolce) ( Table 2) . Thus, the molecular approach, supporting our morphological observations, demonstrates that Clones are ranked according to their "fold increase" value, in ascending order (i.e., the most downregulated clones in DOCA-high-salt hearts being on top of the list). The first column reports the clone ID, according to the NIA17K annotation; the "TaqMan" column shows the gene candidates that were confirmed by real-time PCR; the last four columns report the gene ontology categories, which were significantly overrepresented among the downregulated transcripts: DB, DNA binding (molecular function); RT, regulation of transcription (biological process); TRA, transcription regulatory activity (molecular function); TFA, transcription factor activity (molecular function). The transcripts belonging to one or more of these categories are marked by an "X".
high-salt intake induce differential regulation of gene sets that may contribute to inflammation, vascular remodeling, and production of ECM in normotensive DOCA-treated mice.
The present microarray data, confirmed by real-time PCR and protein analysis on selected candidates, also demonstrate that there is an enriched subset of downregulated genes that code for transcription factors in DOCA-HS hearts. This group includes the interferon-responsive factors Irf1 and Irf2, the early growth response gene Egr1, the activating transcription factor Atf3, the oncogene Junb, the cyclin-dependent protein kinase inhibitor Cdkn2b, and the circadian gene Arntl (also known as Mop3 or Bmal) ( Table 3 ). These transcription factors regulate a variety of important biological functions like circadian rhythmicity, tissue outgrowth, inflammation, wound repair, growth control, and apoptosis. Interestingly, some of these transcription factors, including Irf, Egr and Jun, are also identified as MyD primary response genes, which turn out to play a role in negative growth control, including growth suppression and apoptosis associated with terminal differentiation in many cell types, of both hematopoietic and nonhematopoietic origins (20) . With global cardiac downregulation of these transcription factors after 5 wk of a high-salt diet, we hypothesize the activation of a progrowth and antiapoptotic genetic program that could lead to myocardial hypertrophy and/or vascular neointimal formation in the heart of DOCA mice.
Finally, a preliminary protein analysis indicates that downregulation of Egr1 at the gene and protein level is associated with modulation of the NF-B signaling pathway in DOCA-HS mice. Egr1 was previously reported to modulate NF-B (9). Interestingly, it was also demonstrated that NF-B is, in turn, a regulator of Egr1 expression (30) . Several reports have demonstrated that the DNA binding and transactivating capacity of NF-B is dependent on the phosphorylation status of p65/RelA (6) . Results indicate that even though global protein expression levels of p50 and p65 subunits composing NF-B were relatively unchanged in DOCA-HS vs. DOCA-LS groups, p65 phosphorylated at Ser-276 was significantly downregulated in DOCA-HS nuclear extracts, suggesting a global inactivation of NF-B signaling pathway after 5 wk of high-salt treatment in DOCA mice (6, 31) . The data strongly support the idea that vascular and myocardial remodeling induced by 5 wk of high-salt treatment leads to the activation of a cardioprotective genetic program set to counteract the negative effects induced by high salt on vascular and myocyte physiology (9, 17) . Nevertheless, the data do not allow us to conclude whether changes in NF-B signaling are primary or compensatory in nature. Further studies are required to prove this point.
Perspectives and Significance
In this study, we limited cDNA microarray analysis to DOCA-LS (0.05% and tap water) vs. DOCA-HS (0.3% and 1% fluid), neglecting normal salt concentration (0.3% and tap Fig. 4 . A: Western blots for protein candidates analyzed in DOCA-LS vs. DOCA-HS groups: Collagen III (Col III; ϳ70 kDa), collagen I (Col I; ϳ95 kDa), lipocalin 2 (Lcn2; ϳ25 kDa), early growth response 1 (Egr1; ϳ58 kDa), p65 subunit of NF-B (p65; ϳ65 kDa), and p65 phosphorylated at Ser276 (P.Ser276-p65; ϳ60 kDa); p50 subunit of NF-B (p50; ϳ50 kDa), protein expression levels were normalized to GAPDH expression levels. B: bar graphs show the quantification of protein expression levels for the same protein markers in DOCA-LS vs. DOCA-HS hearts. Data are expressed in arbitrary units. *P Ͻ 0.05, vs. DOCA-LS hearts (n ϭ 6 hearts per group). Graph bars report standard deviations.
water). Correction of hypokalemia by potassium supplementation, along with normalization of high-and low-salt diet groups with additional controls, such as a normal-salt diet or high-salt intake without DOCA, would generate informative data that could detail specific gene expression induced by mineralocorticoid excess and various salt diets. Despite this limitation, our gene expression profiling on normotensive DOCA-salt mice confirms that cardiomyocyte remodeling, inflammation, collagen production, and development of perivascular fibrosis are prominent effects of concomitant exogenous DOCA administration and high-salt diet. The literature concerning the influence of aldosterone on development of cardiac fibrosis is controversial. Multiple investigators have previously reported that excess aldosterone and other mineralocorticoids induce inflammatory cells and markers, leading to the development of vascular inflammation and cardiac fibrosis in hypertensive DOCA-salt rats (3, 37, 38) , whereas conflicting results were shown in vitro and in other in vivo models (12, 18, 25) . Therefore, it was uncertain whether the profibrogenic effect of aldosterone as observed in vivo was due to a direct effect of the hormone on cardiac cells or was the result of indirect, e.g., hypertension-or salt-mediated effects. In this study, without excluding potential effects associated to DOCA/salt-induced hypokalemia and metabolic alkalosis, we clearly demonstrate that among different factors, i.e., hypertension, DOCA, and high-salt intake, the latter is critical for the development of the profibrotic and proinflammatory phenotype observed in the heart of normotensive DOCA-treated mice. Potassium supplementation on target organ (heart and kidney) damage and hypokalemia/metabolic alkalosis need to be further investigated.
